The Harvard University Center for AIDS Research, in collaboration with the Mass General Research Institute, invites you to participate in a two-part event to equip researchers to prepare and present their science in a clear and concise manner to diverse audiences. 

This series, sponsored by the Harvard University CFAR Adolescence and HIV Scientific Working Group, is a unique opportunity to improve your own presentation skills and learn more about ongoing adolescent and HIV research from individuals who will be putting their presentation skills into action. 

In addition to being the Scientific Director of the Mass General Research Institute, Dr. Slaugenhaupt is a Professor in the Department of Neurology at MGH and Harvard Medical School, and an Investigator in the Center for Genomic Medicine. Her research focuses on familial dysautonomia (FD), mucolipidosis type IV (MLIV), as well as the common cardiac disorder of mitral valve prolapse. Discoveries in Dr. Slaugenhaupt’s laboratory have led to the successful implementation of critical population screening for FD and MLIV, and to the development of a treatment for FD directly targeting the mRNA splicing mechanism. In 2013, Dr. Slaugenhaupt was named the Elizabeth G. Riley and Daniel E. Smith, Jr MGH Research Scholar. In 2016, she was honored with a prestigious Javits Neuroscience Investigator Award by the National Institute for Neurological Disorders and Stroke. In the same year, she was named one of the Top Ten Women to Watch ion Science and Technology by the Boston Business Journal. In 2020, she was named the Elizabeth G. Riley and Daniel E. Smith, Jr. Endowed MGH Research Institute Chair.